2U3:FRA
Alcon AG
€ 55.86
arrow_downward
-0.46%(-0.26) Siku 1
7 Okt, 08:35:27 GMT +2 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya 2U3...
Fungua
€ 55.86
Juu
€ 55.86
Chini
€ 55.86
Mtaji wa soko
26.62B
Wastani wa kiasi cha mauzo
135.00
Kiasi cha mauzo ya hisa
15.00
Juu kwa wiki 52
€ 73.96
Chini kwa wiki 52
€ 51.78
Idadi ya wafanyakazi
elfu 25
Fungua
€ 55.86
Juu
€ 55.86
Chini
€ 55.86
Mtaji wa soko
26.62B
Wastani wa kiasi cha mauzo
135.00
Kiasi cha mauzo ya hisa
15.00
Juu kwa wiki 52
€ 73.96
Chini kwa wiki 52
€ 51.78
Idadi ya wafanyakazi
elfu 25
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
AD HOC NEWS
·
saa 4 zilizopita
Alcon stock trades at CHF 52.90 before November 10 earnings
AD HOC NEWS
·
saa 9 zilizopita
Alcon stock pre-market at EUR 56.06: minus 0.05 percent
AD HOC NEWS
·
saa 23 zilizopita
Alcon stock after-hours at EUR 56.24: minus 1.88 percent versus the Lang & Schwarz prior close
AD HOC NEWS
·
siku 2 zilizopita
Alcon stock pre-market at EUR 56.31: minus 0.46 percent
Wasifu
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Kuhusu Alcon AG
Afisa Mkuu Mtendaji (CEO)David J. Endicott
Wafanyakazielfu 25
Lilianzishwa1945
Makao makuuGeneva, Jimbo la Geneva, Uswisi
Sekta-
Tovutialcon.com